Hypertension and renal disease in systemic lupus erythematosus
- PMID: 962443
Hypertension and renal disease in systemic lupus erythematosus
Abstract
A retrospective analysis of 235 patients at the National Institutes of Health who met at least five criteria for systemic lupus erythematosus (SLE) indicated that 45% were hypertensive. Approximately two thirds of these hypertensive patients had creatinine clearances of more than 60 ml/min and nonnephrotic range proteinuria. Only 16% of normotensive patients had creatinine clearances of less than 60 ml/m9n. A subgroup of 36 patients with SLE and with biopsy-proved diffuse renal disease were studied. For these patients, the presence of hypertension could not be correlated with the degree of proteinuria or hematuria, with the level of serum complement, or with the presence of casts, focal necrosis, crescent formation, or interstitial inflammation. Hypertensive patients had a median age of 24.5 years; the majority had creatinine clearances of more than 60 ml/min. In SLE, hypertension is not necessarily associated with advanced renal disease, and high blood pressure may occur relatively early in the course of the disease.
Similar articles
-
Prevalence and clinicopathologic findings of antiphospholipid syndrome nephropathy in Thai systemic lupus erythematosus patients who underwent renal biopsies.Nephrology (Carlton). 2007 Oct;12(5):474-80. doi: 10.1111/j.1440-1797.2007.00792.x. Nephrology (Carlton). 2007. PMID: 17803471
-
Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome.Arthritis Rheum. 2004 Aug;50(8):2569-79. doi: 10.1002/art.20433. Arthritis Rheum. 2004. PMID: 15334471
-
Longterm survival of lupus nephritis patients treated with azathioprine and prednisone.J Rheumatol. 1978 Fall;5(3):275-87. J Rheumatol. 1978. PMID: 372523 Clinical Trial.
-
'Not only...but also': factors that contribute to accelerated atherosclerosis and premature coronary heart disease in systemic lupus erythematosus.Rheumatology (Oxford). 2005 Dec;44(12):1492-502. doi: 10.1093/rheumatology/kei142. Epub 2005 Oct 18. Rheumatology (Oxford). 2005. PMID: 16234277 Review.
-
Factors predicting progression of IgA nephropathies.J Nephrol. 2005 Sep-Oct;18(5):503-12. J Nephrol. 2005. PMID: 16299675 Review.
Cited by
-
Autoimmune therapeutic chloroquine lowers blood pressure and improves endothelial function in spontaneously hypertensive rats.Pharmacol Res. 2016 Nov;113(Pt A):384-394. doi: 10.1016/j.phrs.2016.09.008. Epub 2016 Sep 14. Pharmacol Res. 2016. PMID: 27639600 Free PMC article.
-
Systemic lupus erythematosus--disease management.Springer Semin Immunopathol. 1994;16(2-3):281-94. doi: 10.1007/BF00197522. Springer Semin Immunopathol. 1994. PMID: 7716709 Review. No abstract available.
-
Anti-CD3 antibody therapy attenuates the progression of hypertension in female mice with systemic lupus erythematosus.Pharmacol Res. 2017 Jun;120:252-257. doi: 10.1016/j.phrs.2017.04.005. Epub 2017 Apr 8. Pharmacol Res. 2017. PMID: 28400152 Free PMC article.
-
Blood Growth Factor Levels in Patients with Systemic Lupus Erythematosus: High Neuregulin-1 Is Associated with Comorbid Cardiovascular Pathology.Life (Basel). 2024 Oct 14;14(10):1305. doi: 10.3390/life14101305. Life (Basel). 2024. PMID: 39459605 Free PMC article.
-
Mechanisms of hypertension in autoimmune rheumatic diseases.Br J Pharmacol. 2019 Jun;176(12):1897-1913. doi: 10.1111/bph.14604. Epub 2019 Mar 18. Br J Pharmacol. 2019. PMID: 30714094 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous